Screener
Immunovant, Inc. IMVT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Immunovant, Inc.’s reported figures.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026. Open the filing →
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
FAQ
- What is Immunovant, Inc.'s free cash flow?
- Immunovant, Inc. (IMVT) reported free cash flow of -$95.07M in Q1 2026.
- How has Immunovant, Inc.'s free cash flow changed year-over-year?
- Immunovant, Inc.'s free cash flow increased by 14.2% year-over-year, from -$110.84M to -$95.07M.
- What is the long-term trend for Immunovant, Inc.'s free cash flow?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s free cash flow has grown at a 39.9% compound annual growth rate (CAGR), from -$106.37M to -$407.32M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Immunovant, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude